A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the deadliest cancers.

A new blood test has been found to detect early stage pancreatic cancer with 85% accuracy when used alongside a carbohydrate antigen 19-9 test, according to a study published Feb. 12 in Science ...

He noted that other assays studied in pancreatic cancer have only examined a handful of samples. "When they publish a second ...

Pancreatic cancer is one of the most difficult cancers to detect early, as symptoms often don’t appear until the disease has ...

The American Cancer Society estimates that 67,400 Americans will be diagnosed with pancreatic cancer this year and nearly ...

It happened that the routine section of the pancreas made at autopsy showed extensive metaplasia of the duct epithelium, dilatation of ductules, and acinar and fat necroses and even hyaline ...

Members voted 46-24 to approve House Joint Memorial 1, which if approved by the Senate, would send a letter to the nation’s high court asking it to “restore the natural definition of marriage ...

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, P. R. China ...

Tomorrow's jobs will require the experience and expertise of today's young minds. Elementary students from across the Lakeland Joint School District enjoyed dabbling in age-appropriate robotics ...

Beta Bionics has set the terms for its plan to go public, with a goal of raising at least $114 million to support its artificial pancreas system for people with Type 1 diabetes. The California ...

and radiographic evidence by abdominal ultrasonography or computed tomography (CT) of pancreas involvement. Dose, type of preparation, valproic acid serum levels, duration of time on valproic acid ...

AZD-5863 is under clinical development by AstraZeneca and currently in Phase II for Pancreatic Ductal Adenocarcinoma. According to GlobalData, Phase II drugs for Pancreatic Ductal Adenocarcinoma does ...